C7A.09 is the authoritative medical code for Malignant carcinoid tumors of other sites. This classification is used in medical billing and clinical recording to specify the clinical criteria for malignant carcinoid tumors of other sites (ICD-10-CM C7A.09), ensuring healthcare documentation aligns with 2026 federal coding standards.
Billing Status: NO. This is a clinician non-billable / parent hierarchy grouping in the ICD-10-CM system.
Sequencing, inclusion, and exclusion notes published for C7A.09 in the official ICD-10-CM tabular list.
Conditions not covered by this code, but which may be reported alongside it when both are present.
Additional codes that may be required to fully describe the encounter.
Supplementary codes the tabular list directs you to add.
No. C7A.09 (Malignant carcinoid tumors of other sites) is a non-billable ICD-10-CM category code. A more specific billable subcode must be selected based on clinical documentation.
Per Excludes2 instructions, C7A.09 and the following may both be reported when both are present: malignant pancreatic islet cell tumors (C25.4); Merkel cell carcinoma (C4A.-).
Use additional code(s) to specify: code to identify any associated endocrine syndrome, such as:; carcinoid syndrome (E34.00).
Official ICD-10-CM classifications in the same code family as C7A.09, with their registry titles.
Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures: